Viewing Study NCT03761056


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-01 @ 4:46 AM
Study NCT ID: NCT03761056
Status: COMPLETED
Last Update Posted: 2024-12-04
First Post: 2018-11-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
Sponsor:
Organization: